Firefly Neuroscience is trading 10.94% down at $1.14 after closing at $1.28 on September 17, 2026, with no confirmed specific catalyst for the after-hours decline.
- The company announced a strategic collaboration with Radial to integrate its FDA-cleared Evoke platform into RadialOS.
- No contract value, revenue terms, launch date, or financial guidance were disclosed.
- The announcement did not report or attribute any share-price reaction.